论文信息 - A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial - 字舞流文

A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

R. Stahel | H. Roschitzki-Voser | E. Nadal | S. Popat | S. Rusakiewicz | A. Curioni-Fontecedro | O. Gautschi | J. Spicer | B. Ruepp | M. O'brien | R. Shah | A. Roy | D. Gilligan | W. Janthur | V. Polydoropoulou | R. López Castro | P. Fisher | S. Peters | R. García Campelo | A. Pope | A. Curioni-Fontecedro | R. García Campelo